Sjoerd Rietberg

Sjoerd Rietberg is an experienced investor with a strong background in various sectors, currently active in multiple roles since May 2019. Investments include GNX, focusing on global connectivity solutions; Idris Oncology, which develops technology for enhanced cancer treatment precision; and Interverse, facilitating immersive user experiences in the metaverse. Additionally, Sjoerd advises Agga Capital on digital asset investment strategies and participates in Nectar, which offers investment propositions in social real estate in the Netherlands. Previous investments feature SmartQare BV, Worksuite, and C-Facts, providing tech-driven solutions for various industries. Sjoerd is also a board member of the Flow Traders Foundation, dedicated to combating poverty. Educationally, Sjoerd holds a Master’s degree in Finance from Erasmus University Rotterdam.